[1] |
MAES D, SIBILA M, KUHNERT P, SEGALÉS J, HAESEBROUCK F, PIETERS M. Update on Mycoplasma hyopneumoniae infections in pigs: knowledge gaps for improved disease control. Transboundary and Emerging Diseases, 2018, 65(Suppl 1): 110-124.
doi: 10.1111/tbed.2018.65.issue-S1
|
[2] |
BOURRY O, FABLET C, SIMON G, MAROIS-CRÉHAN C. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs. Veterinary Microbiology, 2015, 180(3/4): 230-236.
doi: 10.1016/j.vetmic.2015.09.015
|
[3] |
MAES D, BOYEN F, DEVRIENDT B, KUHNERT P, SUMMERFIELD A, HAESEBROUCK F. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs. Veterinary Research, 2021, 52(1): 67.
doi: 10.1186/s13567-021-00941-x
|
[4] |
TAO Y, SHU J H, CHEN J, WU Y H, HE Y L. A concise review of vaccines against Mycoplasma hyopneumoniae. Research in Veterinary Science, 2019, 123: 144-152.
doi: 10.1016/j.rvsc.2019.01.007
|
[5] |
LEAL ZIMMER F M A, PAES J A, ZAHA A, FERREIRA H B. Pathogenicity & virulence of Mycoplasma hyopneumoniae. Virulence, 2020, 11(1): 1600-1622.
doi: 10.1080/21505594.2020.1842659
|
[6] |
NING Y R, DING H L. Interaction between Mycoplasma hyopneumoniae and host-A review. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology, 2020, 36(9): 1741-1753.
|
[7] |
MAES D, SEGALES J, MEYNS T, SIBILA M, PIETERS M, HAESEBROUCK F. Control of Mycoplasma hyopneumoniae infections in pigs. Veterinary Microbiology, 2008, 126(4): 297-309.
doi: 10.1016/j.vetmic.2007.09.008
|
[8] |
FOUROUR S, MAROIS-CRÉHAN C, MARTELET L, FABLET C, KEMPF I, GOTTSCHALK M, SEGURA M. Intra-species and inter-species differences in cytokine production by porcine antigen- presenting cells stimulated by Mycoplasma hyopneumoniae, M. hyorhinis, and M. flocculare. Pathogens, 2019, 8(1): 34.
|
[9] |
WOOLLEY L K, FELL S, GONSALVES J R, WALKER M J, DJORDJEVIC S P, JENKINS C, EAMENS G J. Evaluation of clinical, histological and immunological changes and qPCR detection of Mycoplasma hyopneumoniae in tissues during the early stages of mycoplasmal pneumonia in pigs after experimental challenge with two field isolates. Veterinary Microbiology, 2012, 161(1/2): 186-195.
doi: 10.1016/j.vetmic.2012.07.025
|
[10] |
BRITTO C J, COHN L. Bactericidal/Permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease. American Journal of Respiratory Cell and Molecular Biology, 2015, 52(5): 525-534.
doi: 10.1165/rcmb.2014-0297RT
pmid: 25265466
|
[11] |
JAISWAL A K, YADAV J, MAKHIJA S, SANDEY M, SURYAWANSHI A, MITRA A K, MISHRA A. Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging. American Journal of Physiology Lung Cellular and Molecular Physiology, 2022, 322(1): L102-L115.
|
[12] |
CHU H W, THAIKOOTTATHIL J, RINO J G, ZHANG G Y, WU Q, MOSS T, REFAELI Y, BOWLER R, WENZEL S E, CHEN Z Z, ZDUNEK J, BREED R, YOUNG R, ALLAIRE E, MARTIN R J. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. Journal of Immunology, 2007, 179(6): 3995-4002.
doi: 10.4049/jimmunol.179.6.3995
|
[13] |
WU T D, HUANG J, MOORE P J, LITTLE M S, WALTON W G, FELLNER R C, ALEXIS N E, PETER DI Y, REDINBO M R, TILLEY S L, TARRAN R. Identification of BPIFA1/SPLUNC1 as an epithelium-derived smooth muscle relaxing factor. Nature Communications, 2017, 8: 14118.
doi: 10.1038/ncomms14118
pmid: 28165446
|
[14] |
TSOU Y A, TUNG M C, ALEXANDER K A, CHANG W D, TSAI M H, CHEN H L, CHEN C M. The role of BPIFA1 in upper airway microbial infections and correlated diseases. BioMed Research International, 2018, 2021890.
|
[15] |
WU T D, GORIOUNOVA A S, WORTHINGTON E N, WRENNALL J A, GHOSH A, AHMAD S, FLORI SASSANO M, TARRAN R. SPLUNC1 is a negative regulator of the Orai1 Ca(2+) channel. Physiological Reports, 2022, 10(10): e15306.
|
[16] |
BRITTO C J, LIU Q, CURRAN D R, PATHAM B, DELA CRUZ C S, COHN L. Short palate, lung, and nasal epithelial clone-1 is a tightly regulated airway sensor in innate and adaptive immunity. American Journal of Respiratory Cell and Molecular Biology, 2013, 48(6): 717-724.
doi: 10.1165/rcmb.2012-0072OC
pmid: 23470624
|
[17] |
THAIKOOTTATHIL J, CHU H W. MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells. Molecular Immunology, 2011, 49(3): 415-422.
doi: 10.1016/j.molimm.2011.08.005
pmid: 21899893
|
[18] |
ASAI T, OKADA M, ONO M, IRISAWA T, MORI Y, YOKOMIZO Y, SATO S. Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae. Veterinary Immunology and Immunopathology, 1993, 38(3/4): 253-260.
doi: 10.1016/0165-2427(93)90085-I
|
[19] |
甘源, 谢星, 张磊, 熊祺琰, 杨浩, 刘蓓蓓, 韦艳娜, 王海燕, 于岩飞, 白昀, 袁厅, 李俊, 郝飞, 华利忠, 邵国青, 冯志新. 猪肺炎支原体人工感染引起易感猪各肺叶病变差异的研究. 扬州大学学报(农业与生命科学版), 2020, 41(4): 71-76.
|
|
GAN Y, XIE X, ZHANG L, XIONG Q Y, YANG H, LIU B B, WEI Y N, WANG H Y, YU Y F, BAI Y, YUAN T, LI J, HAO F, HUA L Z, SHAO G Q, FENG Z X. Study on the differences of lesions in pulmonary lobes of susceptible pigs artificially infected Mycoplasma hyopneumoniae. Journal of Yangzhou University (Agricultural and Life Science Edition), 2020, 41(4): 71-76. (in Chinese)
|
[20] |
ZHANG Z Z, WANG H Y, XIE X, CHEN R, LI J, NI B, YU P, LIU Z F, SHAO G Q, XIONG Q Y, WEI Y N, LIU B B, FENG Z X, ZHOU X, ZHANG C. Long-residence pneumonia vaccine developed using PEG-grafted hybrid nanovesicles from cell membrane fusion of Mycoplasma and IFN-γ-primed macrophages. Small, 2021, 17(34): e2101183.
|
[21] |
WANG H Y, ZHANG Z Z, XIE X, LIU B B, WEI Y N, GAN Y, YUAN T, NI B, WANG J, ZHANG L, XIONG Q Y, SHAO G Q, FENG Z X. Paracellular pathway-mediated Mycoplasma hyopneumoniae migration across porcine airway epithelial barrier under air-liquid interface conditions. Infection and Immunity, 2020, 88(10): e00470-e00420.
|
[22] |
GARCIA-CABALLERO A, RASMUSSEN J E, GAILLARD E, WATSON M J, OLSEN J C, DONALDSON S H, STUTTS M J, TARRAN R. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(27): 11412-11417.
|
[23] |
魏婧洁, 蒋宁波, 梁燕, 张倩, 孙英健, 胡格. 苦参碱对H9N2 AIV感染小鼠NLRP3炎性体信号通路的影响. 中国农业科学, 2022, 55(21): 4315-4326.
doi: 10.3864/j.issn.0578-1752.2022.21.017
|
|
WEI J J, JIANG N B, LIANG Y, ZHANG Q, SUN Y J, HU G. Effect of matrine on NLRP3 inflammasome signaling pathway in H9N2 AIV infected mice. Scientia Agricultura Sinica, 2022, 55(21): 4315-4326. (in Chinese)
doi: 10.3864/j.issn.0578-1752.2022.21.017
|
[24] |
SIMIONATTO S, MARCHIORO S B, MAES D, DELLAGOSTIN O A. Mycoplasma hyopneumoniae: From disease to vaccine development. Veterinary Microbiology, 2013, 165(3/4): 234-242.
doi: 10.1016/j.vetmic.2013.04.019
|
[25] |
LIU Y, BARTLETT J A, DI M E, BOMBERGER J M, CHAN Y R, GAKHAR L, MALLAMPALLI R K, MCCRAY P B Jr, DI Y P. SPLUNC1/BPIFA 1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection. The American Journal of Pathology, 2013, 182(5): 1519-1531.
doi: 10.1016/j.ajpath.2013.01.050
|
[26] |
DEBEY M C, ROSS R F. Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures. Infection and Immunity, 1994, 62(12): 5312-5318.
doi: 10.1128/iai.62.12.5312-5318.1994
|
[27] |
MOLDOVEANU B, OTMISHI P, JANI P, WALKER J, SARMIENTO X, GUARDIOLA J, SAAD M, YU J. Inflammatory mechanisms in the lung. Journal of Inflammation Research, 2009, 2: 1-11.
pmid: 22096348
|
[28] |
WRENNALL J A, AHMAD S, WORTHINGTON E N, WU T D, GORIOUNOVA A S, VOELLER A S, STEWART I E, GHOSH A, KRAJEWSKI K, TILLEY S L, HICKEY A J, SASSANO M F, TARRAN R. A SPLUNC1 peptidomimetic inhibits Orai1 and reduces inflammation in a murine allergic asthma model. American Journal of Respiratory Cell and Molecular Biology, 2022, 66(3): 271-282.
doi: 10.1165/rcmb.2020-0452OC
|
[29] |
DI Y P. Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria. Biochemical Society Transactions, 2011, 39(4): 1051-1055.
doi: 10.1042/BST0391051
pmid: 21787346
|
[30] |
VLAHOS R. SPLUNC1 α6 peptidomimetic: A novel therapeutic for asthma. American Journal of Respiratory Cell and Molecular Biology, 2022, 66(3): 241-242.
doi: 10.1165/rcmb.2021-0451ED
|